Position in CELC
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$33,745,719
-$1,104,035 QoQ
Shares Held
295,652
-15.4% QoQ
Ownership
0.606%
of shares outstanding
% of Portfolio
13.32%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Pfizer Inc holds $253,428,635 across 16 Biotechnology names. CELC ranks #4 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ORIC |
Oric Pharmaceuticals, Inc.
|
4,780,401 | $60,567,680 | |
| 2 | ALLO |
Allogene Therapeutics, Inc.
|
22,032,040 | $53,758,177 | |
| 3 | ARVN |
Arvinas, Inc.
|
3,457,815 | $36,652,839 | |
| 4 | CELC |
Celcuity Inc.
This page
|
295,652 | $33,745,719 | |
| 5 | ZURA |
Zura Bio Ltd
|
2,838,913 | $16,891,532 | |
| 6 | WVE |
Wave Life Sciences Ltd.
|
1,875,000 | $13,593,750 | |
| 7 | PYXS |
Pyxis Oncology, Inc.
|
7,032,770 | $10,267,843 | |
| 8 | CRBU |
Caribou Biosciences, Inc.
|
4,690,431 | $8,911,818 |
All Filings in CELC
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33,745,719 | 295,652 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $34,849,754 | 349,406 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $17,260,656 | 349,406 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,664,570 | 349,406 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $3,532,494 | 349,406 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,573,724 | 349,406 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||